ReviewTherapeutic advances in medical oncology2026
Biomarker testing in advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2 negative breast cancer: expert recommendations.
Tomás Reinert et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.